Start an analysis for ATEX
Anterix Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $250m | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Remaining authorization | $250m | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Program expiry | 22-Sep-29 | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 16-Sep-26 | $250m | $250m | 22-Sep-29 | On September 16, 2026, the Board authorized the 2026 Share Repurchase Program (the “2026 Share Repurchase Program”), which became effective on September 22, 2026, pursuant to which the Company may repurchase up to $250.0 million of the Company’s common stock on or before September 22, 2029.10-Q filed 10-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 10-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 10-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 10-Nov-26 |